Key facts
- Zeus (Therapeutic Devices)’s last known valuation is $4.9M (Mar 2025).
- It has raised $930K; the latest was Early Stage VC ($930K) in Mar 2025.
- Notable investors include SyndicateRoom, British Design Fund, King's College London, WilkinsonFuture, Your VC.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Zeus (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Zeus (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zeus (Therapeutic Devices)
Developer of a non-invasive anti-snoring device designed to improve sleep and rest. The company offers a device that tackles snoring by gently stimulating tongue muscles to keep airways open during sleep, enabling individuals to enhance the quality of sleep and reduce the likelihood of negative related illness.
- Sector
- Healthcare
- HQ
- Petersfield, United Kingdom
- Founded
- 2022
- Employees
- 3
- Website
- zeussleeps.com/
- Ownership
- Privately Held (backing)
Zeus (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zeus (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zeus (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.